IP Library Granted Patent US 10,005,813
Granted Patent B2
US 10,005,813 · App. 15/603,290 · Granted Jun 26, 2018

Methods for the purification of deoxycholic acid

Inventors: Robert M. Moriarty (Michiana Shores, IN); Achampeta Rathan Prasad (Hyderabad, IN); John Gregory Reid (Groton, MA); Roy A. Swaringen, Jr. (Durham, NC)
Assignee: Kythera Biopharmaceuticals, Inc.
C07J9/005A61K31/575C07J1/0011C07J5/0053C07J9/00C07J13/007C07J41/0061Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,005,813
App. No.
15/603,290
Granted
Jun 26, 2018
Kind
B2
Abstract

Synthetic methods for preparing deoxycholic acid and intermediates thereof, high purity synthetic deoxycholic acid, compositions and methods of use are provided. Also, provided are processes for the synthesis of 12-keto or 12-α-hydroxysteroids from Δ-9,11-ene, 11-keto or 11-hydroxy-β-steroids. This invention is also directed to novel compounds prepared during the synthesis. This invention is also directed to the synthesis of deoxycholic acid starting from hydrocortisone.

Claims (23)

1. A compound of formula 1:

wherein

Pg is a hydroxyl protecting group,

R is hydrogen, hydroxyl, or —OPg, R 1 is the 17-side chain of a bile acid selected from the group consisting of cholic acid, deoxycholic acid, taurocholic acid, and glycocholic acid, wherein the carboxyl functionality of said side chain is optionally esterified with a C 1 -C 6 alkyl group, and R 2 is hydrogen, or R 1 and R 2 together with the carbon atom attached thereto form a keto or a keto protecting group, and

each of R 3 , R 4 and R 5 is independently C 1 -C 3 alkyl.

2. The compound of claim 1 , wherein the compound of formula 1 is selected from the group consisting of compounds 42, 43, 44, 45 and 46:

3. A compound of formula 5

wherein

Pg is a hydroxyl protecting group;

R is hydrogen, hydroxyl, or —OPg, R 1 is the 17-side chain of a bile acid selected from the group consisting of cholic acid, deoxycholic acid, taurocholic acid, and glycocholic acid, wherein the carboxyl functionality of said side chain is optionally esterified with a C 1 -C 6 alkyl group, and R 2 is hydrogen, or R 1 and R 2 together with the carbon atom attached thereto form a keto or a keto protecting group; and each of R 3 , R 4 and R 5 is independently C 1 -C 3 alkyl.

4. The compound of claim 3 , wherein the compound of formula 5 is selected from the group consisting of compounds 48, 49, 50, 51 and 52:

5. The compound of claim 1 , wherein R 1 is selected from the group consisting of

wherein R 6 is lower alkyl and the wavy line represents the point of connection to the 17-position of steroidal scaffold.

6. The compound of claim 1 , wherein R 1 and R 2 together with the carbon atom attached thereto form a keto group.

7. The compound of claim 1 , wherein R 1 and R 2 together with the carbon atom attached thereto form:

wherein n is 1, 2, or 3 and the wavy line represents the point of connection to the rest of the molecule.

8. The compound of claim 1 , wherein R is hydrogen.

9. The compound of claim 3 , wherein R 1 is selected from the group consisting of

wherein R 6 is lower alkyl and the wavy line represents the point of connection to the 17-position of steroidal scaffold.

10. The compound of claim 3 , wherein R 1 and R 2 together with the carbon atom attached thereto form a keto group.

11. The compound of claim 3 , wherein R 1 and R 2 together with the carbon atom attached thereto form:

wherein n is 1, 2, or 3 and the wavy line represents the point of connection to the rest of the molecule.

12. The compound of claim 3 , wherein R is hydrogen.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Oct 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050657/0305 →
CHANGE OF NAME Recorded Oct 4, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050638/0086 →
Priority Claims (1)
GB 1008726.0 · May 25, 2010 · national
Continuity (7)
Continuation 14532940 · Nov 4, 2014
Continuation 13140421
Provisional Application 61288132 · Dec 18, 2009
Provisional Application 61302007 · Feb 5, 2010
Provisional Application 61303816 · Feb 12, 2010
Provisional Application 61348686 · May 26, 2010
Related Publication 20170320905A1 · Nov 9, 2017